CBIO
CRESCENT BIOPHARMA, INC.
NASDAQ · Healthcare · Biotechnology · US
$16.89
+0.72%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 878.31x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.84x
- Price / sales
- 52.79x
- Price / cash flow
- -8.63x
Enterprise value
- Enterprise value
- $461.2M
- EV / sales
- 38.81x
- EV / EBITDA
- -2.83x
- EV / EBIT
- -2.74x
- Market cap
- $627.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026